A phase I/II trial on combining radiation with immunotherapy for breast cancer recurrence found 79% of treated skin tumors responded when imiquimod cream was paired with targeted radiation.
This post covers a mouse model study exploring triple negative breast cancer immunotherapy options through a three-drug approach targeting T cell exhaustion in the tumor microenvironment.
Why doesn't immunotherapy work for my cancer? This post covers new research on hidden tumor targets in non-coding DNA that standard mutation tests completely miss.
New research into cancer "dark matter" reveals hidden cancer signals immune system can't find, offering a fuller picture of why immunotherapy fails for many patients.
Can nanotechnology reduce breast cancer drug side effects? This preclinical study found a dual-drug nanoparticle system cut tumor growth by 72.93% in mice.
This review explains the science behind cold tumor hot tumor immunotherapy how to switch, focusing on how nanocarrier delivery may reshape treatment precision in ongoing research.
Are all stem cell treatments the same? This review covers how MSC subpopulations defined by specific markers may explain inconsistent results seen across cell therapy trials.